Literature DB >> 16902962

The stanniocalcin family of proteins.

Graham F Wagner1, Gabriel E Dimattia.   

Abstract

Stannniocalcin (STC) is a polypeptide hormone that was originally identified in bony fishes as a systemic regulator of mineral metabolism, and is best known for its regulatory effects on calcium/phosphate transport by the gills, gut and kidneys. The mammalian homolog to fish STC was discovered in 1995 and has resulted in progressively growing interest ever since as to its possible role in humans. Moreover, new discoveries in the mammalian STC field are resulting in significant reappraisals as to its role in fishes. Perhaps the most significant of these has been the discovery of a second gene encoding stanniocalcin-related protein, or STC-2, first in mammals and subsequently in fish. This review covers the comparative endocrinology of the STCs in fishes and mammals from the perspectives of structure, function and regulation. It then delves into some of the newer aspects of STC-1/STC-2 biology that have been uncovered using both classical and transgenic approaches. Of these, one of the most intriguing discoveries relates to the receptor-mediated sequestration of STC by target cell organelles. The functions of other newly discovered mammalian and fish STC variants are also discussed, as is the recent discovery of STC-related homologs in invertebrates. Based on our current state of knowledge, it is apparent that STC has an ancient lineage and that the STC family of proteins is proving to have significant roles in metabolism, reproduction and development. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16902962     DOI: 10.1002/jez.a.313

Source DB:  PubMed          Journal:  J Exp Zool A Comp Exp Biol        ISSN: 1548-8969


  33 in total

1.  Human stanniocalcin-1 or -2 expressed in mice reduces bone size and severely inhibits cranial intramembranous bone growth.

Authors:  Jennifer Johnston; Yudith Ramos-Valdes; Lee-Anne Stanton; Sadia Ladhani; Frank Beier; Gabriel E Dimattia
Journal:  Transgenic Res       Date:  2010-02-20       Impact factor: 2.788

2.  Multiple signaling pathways involved in stimulation of osteoblast differentiation by N-methyl-D-aspartate receptors activation in vitro.

Authors:  Jie-li Li; Lin Zhao; Bin Cui; Lian-fu Deng; Guang Ning; Jian-min Liu
Journal:  Acta Pharmacol Sin       Date:  2011-06-20       Impact factor: 6.150

3.  Stanniocalcin 2 is a negative modulator of store-operated calcium entry.

Authors:  William Zeiger; Daisuke Ito; Carol Swetlik; Masatsugu Oh-hora; Mitchel L Villereal; Gopal Thinakaran
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

4.  Clinical utility of measuring expression levels of Stanniocalcin 2 in patients with colorectal cancer.

Authors:  Shahryar Hashemzadeh; Amir Ahmad Arabzadeh; Mehrdad Asghari Estiar; Masoud Sakhinia; Nahid Mesbahi; Leila Emrahi; Morteza Ghojazadeh; Ebrahim Sakhinia
Journal:  Med Oncol       Date:  2014-09-19       Impact factor: 3.064

5.  trpm7 regulation of in vivo cation homeostasis and kidney function involves stanniocalcin 1 and fgf23.

Authors:  Michael R Elizondo; Erine H Budi; David M Parichy
Journal:  Endocrinology       Date:  2010-09-29       Impact factor: 4.736

6.  The corpuscles of Stannius, calcium-sensing receptor, and stanniocalcin: responses to calcimimetics and physiological challenges.

Authors:  Michael P Greenwood; Gert Flik; Graham F Wagner; Richard J Balment
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

7.  Low-resolution structural studies of human Stanniocalcin-1.

Authors:  Daniel M Trindade; Júlio C Silva; Margareth S Navarro; Iris C L Torriani; Jörg Kobarg
Journal:  BMC Struct Biol       Date:  2009-08-27

8.  Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio.

Authors:  Steve Mangos; Ansel P Amaral; Christian Faul; Harald Jüppner; Jochen Reiser; Myles Wolf
Journal:  Nephrol Dial Transplant       Date:  2012-08-11       Impact factor: 5.992

Review 9.  Mammalian stanniocalcin-1 activates mitochondrial antioxidant pathways: new paradigms for regulation of macrophages and endothelium.

Authors:  David Sheikh-Hamad
Journal:  Am J Physiol Renal Physiol       Date:  2009-08-05

10.  Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity.

Authors:  Jian Guan; Shikha Mishra; Jianru Shi; Eva Plovie; Yiling Qiu; Xin Cao; Davide Gianni; Bingbing Jiang; Federica Del Monte; Lawreen H Connors; David C Seldin; Francesca Lavatelli; Paola Rognoni; Giovanni Palladini; Giampaolo Merlini; Rodney H Falk; Marc J Semigran; G William Dec; Calum A Macrae; Ronglih Liao
Journal:  Basic Res Cardiol       Date:  2013-08-28       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.